期刊文献+

2001年~2004年四川广安市6家医院抗感染药利用分析 被引量:8

Analysis of the Use of Anti-infectives in6Hospitals of Guang'an City from 2001 to 2004
暂未订购
导出
摘要 目的:为抗感染药的应用、管理提供参考依据。方法:对四川广安市6家医院2001年~2004年抗感染药的销售金额、用药频度(DDDs)等数据进行统计、分析。结果:口服洛美沙星DDDs连续4年均居口服用药的前1、2位;异烟肼、利福平DDDs连续4年分别居前4、5位;注射用青霉素DDDs(2001年~2003年)居注射剂的首位。左氧氟沙星不论是销售金额,还是DDDs都呈后来居上之势。结论:该地区医疗机构抗感染药销售金额与药品销售总金额的比例同西南地区其它医疗机构接近,新品种较少,用药档次偏低。 OBJECTIVE:To provide references for the application and management of anti-infectives.METHODS:Data on sale volume,DDDs etc.of anti-infection drugs in6hospitals of Guang'an city from2001to2004were statistically analyzed.RESULTS:The DDDs of oral lomefloxacin dominated the first or2nd places for the4years;The DDDs rank orders of isoniazid and rifampin were No.4and No.5respectively in the4years;The DDDs of penicillin for injection dominated the first place on the injectable preparation lists(2001~2003);The latecomer levofloxacin assumed the tendency of surpassing the early starters not only in sale volume but also the DDDs.CONCLUSION:The proportion for anti-infectives in sales volume to the sum total drug consumption of the above mentioned area were close to those of the other medical institutions in southwest area,there are less new drug varieties and the grade of drugs used in the area was low.
出处 《中国药房》 CAS CSCD 北大核心 2005年第14期1073-1076,共4页 China Pharmacy
关键词 抗感染药 销售金额 用药频度 排序 Anti-infectives Sales volume DDDs Sequence
  • 相关文献

参考文献2

二级参考文献14

  • 1夏培元,肖光夏.细菌对抗生素的耐药性—— 一个必须面对的严重问题[J].中华烧伤杂志,2001,17(2):7-10. 被引量:24
  • 2李仲兴 郑家齐.诊断细菌学[M].香港:黄河文化出版社,1992.295-297.
  • 3王金良 徐迎春.抗微生物药物敏感性试验规范[M].上海:上海科技出版社,2002.24.
  • 4Hoshino K, Kitamura A, Morrissey I, et al .Comparison of inhibition of Escherichia coli topoisomerase IV by quinolones with DNA gyrase inhibition[J] .Antimicrob Agents Chemother, 1994,38(11) .2 623.
  • 5Goldstein FW,Acar JF. Epidemiology of quinolone resistance: Europe and North and South America[J]Drugs, 1995,49 ( suppl 2) : 36.
  • 6Chen DK, McGeer A, de Azavedo JC, et al. Decreased susceptibility of streptococcus pneumoniae to fluoroquinolones in Canada. Canadian bacterial surveillance network [ J ] . N Engl J Med , 1999,341: 233.
  • 7Jones RN, Pfaller MA. Can antimicrobial susceptibility testing results for ciprofloxacin or levofloxacin predict susceptibility to a newer fluoroquinolone, gatifloxacin?: Report from the sentry antimicrobial surveillance program (1997-- 1999) [J] . Diagnostic Microbilogy and Infectious Disease, 2001,39: 237.
  • 8Lopez-Hernadez S, Alarcon T, Delgado T, et al. In vitro activity of β-Lactam agents and β-Lactmnase inhibitors in clinical isolates of acinetobacter baumannii[ J ]. Rev Esp Quimioter, 1999,12 (2) :140.
  • 9Jones RN, Pfatler MA, Doem GV, et al. Antimicrobial activity and spectrum investigation of eight broad-spectrum -βLactam drugs: a 1997 surveillance trial in 102 medical centers in the United States[J]. Dingn Microbiol Inect Dis, 1998,30:215.
  • 10Pfaller MA, Jones RN, Doem GV, et al. Multicenter evalution of the antimicrobial activity for six broad-spectrum β-Lactarns in Veneauela using the E test method[J ]. Diagn Microbiol Infect Dis, 1998,30:45.

共引文献23

同被引文献25

引证文献8

二级引证文献12

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部